MedPath
HSA Approval

BIOLAX TABLET 5 mg

SIN08243P

BIOLAX TABLET 5 mg

BIOLAX TABLET 5 mg

July 4, 1995

BENSON HEALTHCARE PTE LTD

BENSON HEALTHCARE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBENSON HEALTHCARE PTE LTD
Licence HolderBENSON HEALTHCARE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

ENTERIC COATED TABLET

ORAL

Medical Information

A06AB02

bisacodyl

Manufacturer Information

BENSON HEALTHCARE PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

BISACODYL

5 mg

Bisacodyl

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BIOLAX TABLET 5 mg - HSA Approval | MedPath